Genetics of Ataxias: Hereditary Forms

REFERENCES

1. 1.↵
   1. Manto M,
   2. Marmolino D

   . Cerebellar ataxias. Curr Opin Neurol 2009;22:419–29

   CrossRefPubMed
2. 2.↵
   1. Manto MU

   . The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 2005;4:2–6

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Klockgether T

   . Update on degenerative ataxias. Curr Opin Neurol 2011;24:339–45

   CrossRefPubMed
4. 4.↵
   1. Harding AE

   . Classification of the hereditary ataxias and paraplegias. Lancet 1983;1:1151–55

   PubMedWeb of Science
5. 5.↵
   1. Schöls L,
   2. Bauer P,
   3. Schmidt T,
   4. et al

   . Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291–304

   CrossRefPubMedWeb of Science
6. 6.↵
   1. McMurray CT

   . Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet 2010;11:786–99

   CrossRefPubMed
7. 7.↵
   1. Sailer A,
   2. Houlden H

   . Recent advances in the genetics of cerebellar ataxias. Curr Neurol Neurosci Rep 2012;12:227–36

   CrossRefPubMed
8. 8.↵
   1. Schmitz-Hübsch T,
   2. Klockgether T

   . An update on inherited ataxias. Curr Neurol Neurosci Rep 2008;8:310–19

   PubMed
9. 9.↵
   1. Brusse E,
   2. Maat-Kievit JA,
   3. van Swieten JC

   . Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 2007;71:12–24

   PubMed
10. 10.↵
    1. Wüllner U,
    2. Klockgether T,
    3. Petersen D,
    4. et al

    . Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology 1993;43:318–25

    CrossRef
11. 11.↵
    1. Döhlinger S,
    2. Hauser TK,
    3. Borkert J,
    4. et al

    . Magnetic resonance imaging in spinocerebellar ataxias. Cerebellum 2008;7:204–14

    PubMed
12. 12.↵
    1. Guerrini L,
    2. Lolli F,
    3. Ginestroni A,
    4. et al

    . Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2: a quantitative volumetric, diffusion and proton spectroscopy MR study. Brain 2004;127(pt 8):1785–95

    Abstract/FREE Full Text
13. 13.↵
    1. Schulz JB,
    2. Borkert J,
    3. Wolf S,
    4. et al

    . Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 2010;49:158–68

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Margulis BA,
    2. Vigont V,
    3. Lazarev VF,
    4. et al

    . Pharmacological protein targets in polyglutamine diseases: mutant polypeptides and their interactors. FEBS Lett 2013;587:1997–2007

    CrossRefPubMedWeb of Science